相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Estrogen and Progesterone Receptor Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Guideline Update
Kimberly H. Allison et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
Guoxuan Gao et al.
BMC CANCER (2020)
Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2-) Breast Cancer
Yuanping Hu et al.
CLINICAL BREAST CANCER (2020)
The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer
Li Chen et al.
ONCOTARGETS AND THERAPY (2020)
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy
Maria Vittoria Dieci et al.
EUROPEAN JOURNAL OF CANCER (2020)
Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Ileana Corbeau et al.
CANCERS (2020)
PERCEPTION Trial protocol Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer
Sejdi Lusho et al.
MEDICINE (2020)
Locally advanced breast cancer: Tumor-infiltrating lymphocytes as a predictive factor of response to neoadjuvant chemotherapy
Leonardo Russo et al.
EJSO (2019)
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients
Vincenzo Graziano et al.
BREAST (2019)
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals
Wanying Guo et al.
CANCER MEDICINE (2019)
Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation
Sandra Romero-Cordoba et al.
CANCERS (2019)
Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
Jieun Lee et al.
CANCER RESEARCH AND TREATMENT (2019)
Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients
Joanna Huszno et al.
ONCOLOGY LETTERS (2019)
Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer
Dilan A. Patel et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes
Yuka Asano et al.
ANTICANCER RESEARCH (2018)
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
Marie Beguinot et al.
BMC CANCER (2018)
Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer
S. Chae et al.
CURRENT ONCOLOGY (2018)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
Claudio Vernieri et al.
SCIENTIFIC REPORTS (2018)
The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis
Joanna L. Sylman et al.
FRONTIERS IN ONCOLOGY (2018)
Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
Miao Ruan et al.
DIAGNOSTIC PATHOLOGY (2018)
Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer
Uiju Cho et al.
PLOS ONE (2018)
Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis
Gaowen Chen et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Joo Ho Lee et al.
ANTICANCER RESEARCH (2018)
Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer
Javier Cuello-Lopez et al.
PLOS ONE (2018)
Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer
Kuojun Ren et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Priyanka Sharma et al.
CLINICAL CANCER RESEARCH (2018)
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer
Tithi Biswas et al.
ONCOTARGET (2017)
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67
Bojana Jovanovic et al.
CLINICAL CANCER RESEARCH (2017)
Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer
Yuka Asano et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis
Ke Wang et al.
ONCOTARGET (2016)
Platelet-Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer
Yuka Asano et al.
PLOS ONE (2016)
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
Mirco Pistelli et al.
BMC CANCER (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study
M. V. Dieci et al.
ANNALS OF ONCOLOGY (2014)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Elevated Serum Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Could be Useful in Lung Cancer Diagnosis
Yasemin Kemal et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
Suee Lee et al.
BMC CANCER (2013)
Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome
Olivier Tredan et al.
EUROPEAN JOURNAL OF CANCER (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients
Katarzyna Pogoda et al.
MEDICAL ONCOLOGY (2013)
Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer
Hyuk-Chan Kwon et al.
BIOMARKERS (2012)
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
Makiko Ono et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Elevated Preoperative Neutrophil to Lymphocyte Ratio Predicts Poor Survival Following Resection in Late Stage Gastric Cancer
Mi Ran Jung et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
Richard A. Smith et al.
AMERICAN JOURNAL OF SURGERY (2009)
Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
Farrah Kassam et al.
CLINICAL BREAST CANCER (2009)
Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer
Frederique Penault-Llorca et al.
HUMAN PATHOLOGY (2008)
Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
分享论文
